Probi was founded in 1991 by University of Lund researchers seeking to commercialize a probiotic bacterium that they had identified as being therapeutic for seriously ill people. Since then, the Swedish company has had modest commercial success, with one beverage licensee in Scandanivia providing about two-thirds of its $4.8 million in royalty revenues last year.
But Probi is poised for breakout growth in the next year or so, according to CEO Per Bengtsson. The compa
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.